Star Surgical Shines as U.S. Outlook Improves for 2024

Key PointsSTAAR Surgical is the leading maker of implantable ocular lenses (IOL) used for cataract surgery.Its EVO ICL sales hit the highest levels in the United States in Q1 2024 since its FDA approval in March 2022.With over 90% of people over 65 years of age developing cataracts, STAAR Surgical has a long runway for growth from the aging population.5 stocks we like better than STAAR SurgicalSTAAR Surgical Co. NASDAQ: STAA develops and manufactures intraocular lenses (IOL) used to replace a person's natur ...